Pear Therapeutics

Andrew Schwab

Mr. Schwab has served as a member of Pear’s board of directors since June 2014 and is a member of the Nominating and Corporate Governance Committee. Mr. Schwab has served as the co-chief executive officer and as a member the board of directors of 5:01 Acquisition Corp (Nasdaq: FVAM) since its inception in August 2020. Mr. Schwab is a founding partner and managing member of 5AM Venture Management, LLC and also a managing member of 5AM Partners IV, LLC and 5AM Opportunities I (GP), LLC, the general partner entities of major shareholders of Pear. Prior to founding 5AM Venture Management, LLC in 2002, Mr. Schwab was a principal at Bay City Capital, where he was involved with companies such as Cubist Pharmaceuticals, Inc; PTC Therapeutics, Inc; Symyx Technologies, Inc; and Syrrx, Inc. Previously, Mr. Schwab was vice president of Business Development at Digital Gene Technologies, Inc and a vice president in the life science investment banking group of Montgomery Securities. At 5AM, he has led the firm’s investments in and served on the boards of Bird Rock Bio, Inc; BlueLight Therapeutics, Inc; Camp4 Therapeutics Corporation; Cleave Therapeutics, Inc; DVS Sciences, Inc (which was acquired by Fluidigm Corporation); Escient Pharmaceuticals, Inc; Flexion Therapeutics, Inc (Nasdaq: FLXN); Ikaria, Inc (which was acquired by Mallinckrodt plc and spun out Bellerophon Therapeutics, Inc [Nasdaq: BLPH]); Ilypsa, Inc (which was acquired by Amgen, Inc); Miikana Therapeutics, Inc (which was acquired by EntreMed, Inc); Novome Biotechnologies, Inc; Panomics Inc (which was acquired by Affymetrix, Inc); Precision NanoSystems, Inc (which was acquired by Danaher Corporation); Purigen Biosystems, Inc; Synosia Therapeutics Holding AG (which was acquired by Biotie Therapies Corp); Rarecyte, Inc; The Assay Depot (dba; TMRW Life Sciences, Inc; and Viveve Medical, Inc (Nasdaq: VIVE). Mr. Schwab also currently serves on the boards of trustees of the California Academy of Sciences and Davidson College. Mr. Schwab earned a BS degree with honors in genetics and ethics from Davidson College.